Clicky

Sino Biopharmaceutical Ltd(1177)

Description: Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.


Keywords: Pharmaceutical Products Medication Pharmacology Active Pharmaceutical Ingredients Consultation Services Hepatitis Tablet Chemical Engineering Health Food Injection Health Technology Ophthalmic Products Medical Management Amlodipine Besylate Edaravone Yinishu Aprepitant Colistimethate Sodium Lenvatinib Sofosbuvir

Home Page: www.sinobiopharm.com

Office Tower
Wan Chai,
Hong Kong
Phone: 852 2802 9886


Officers

Name Title
Ms. Y. Y. Tse Exec. Chairwoman of the Board
Mr. Eric S. Y. Tse CEO & Exec. Director
Mr. Ping Tse Founder & Sr. Vice Chairman
Ms. Cheung Ling Cheng Exec. Vice Chairwoman of the Board
Ms. Mingqin Li VP & Exec. Director
Mr. Zhoushan Tian Exec. Director
Mr. Hsin Tse VP & Exec. Director
Ms. Fai Chia VP & Assistant to the Founding Chairman
Dr. Wei Nong Ye Assistant to Founding Chairman & GM of R&D Department
Ms. Wun Tse Assistant to the Founding Chairman

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 20.8333
Trailing PE: 11.0889
Price-to-Book MRQ: 2.5364
Price-to-Sales TTM: 3.1038
IPO Date: 2000-09-29
Fiscal Year End: December
Full Time Employees: 25552
Back to stocks